AI Verdict
JAZZ has stronger fundamentals based on our AI analysis.
JBDI vs JAZZ Fundamental Comparison
| Metric | JBDI | JAZZ |
|---|---|---|
| Revenue | N/A | $4.3B |
| Net Income | N/A | $-356.1M |
| Net Margin | N/A | -8.3% |
| ROE | N/A | -8.2% |
| ROA | N/A | -3.1% |
| Current Ratio | N/A | 1.86x |
| Debt/Equity | N/A | 1.24x |
| EPS | N/A | $-5.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
JBDI vs JAZZ: Frequently Asked Questions
Is JBDI or JAZZ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), JAZZ has stronger fundamentals. JBDI is rated STRONG SELL (95% confidence) while JAZZ is rated SELL (78% confidence). This is not investment advice.
How does JBDI compare to JAZZ fundamentally?
JBDI Holdings Ltd has ROE of N/A vs Jazz Pharmaceuticals plc's -8.2%. Net margins are N/A vs -8.3% respectively.
Which stock pays higher dividends, JBDI or JAZZ?
JBDI has a dividend yield of N/A or no dividend while JAZZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in JBDI or JAZZ for long term?
For long-term investing, consider that JBDI has STRONG SELL rating with 95% confidence, while JAZZ has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about JBDI vs JAZZ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For JBDI vs JAZZ, the AI consensus favors JAZZ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.